Dudley Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$808K Buy
10,324
+460
+5% +$37.1K 0.32% 71
2026
Q1
$855K Hold
9,864
0.38% 63
2025
Q4
$948K Sell
9,864
-27
-0.3% -$2.62K 0.41% 59
2025
Q3
$942K Sell
9,891
-240
-2% -$22.1K 0.42% 55
2025
Q2
$883K Buy
10,131
+189
+2% +$16K 0.44% 54
2025
Q1
$893K Sell
9,942
-685
-6% -$61.3K 0.47% 54
2024
Q4
$849K Sell
10,627
-4,690
-31% -$406K 0.43% 56
2024
Q3
$1.38M Sell
15,317
-324
-2% -$27.3K 0.71% 39
2024
Q2
$1.23M Sell
15,641
-1,065
-6% -$87.3K 0.68% 40
2024
Q1
$1.45M Hold
16,706
0.85% 35
2023
Q4
$1.38M Sell
16,706
-650
-4% -$49.5K 0.88% 36
2023
Q3
$1.36M Buy
17,356
+51
+0.3% +$4.27K 0.95% 32
2023
Q2
$1.52M Buy
17,305
+485
+3% +$41.8K 1.03% 30
2023
Q1
$1.36M Buy
16,820
+910
+6% +$74.2K 0.92% 35
2022
Q4
$1.24M Buy
+15,910
New +$1.29M 0.87% 37

Other funds holding MDT

Dudley Capital Management's MDT Position: Q2 2026 in Review

Dudley Capital Management increased its Medtronic (MDT) stake by 4.7% in Q2 2026, buying an estimated $37.1K and bringing the position to 10,324 shares worth $808K. The position accounts for 0.32% of the portfolio, ranked #71.

Dudley Capital Management first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.52M in Q2 2023. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Dudley Capital Management held 10,324 shares of Medtronic worth $808K as of Q2 2026.
  • Dudley Capital Management bought 460 Medtronic shares in Q2 2026, an estimated $37.1K.
  • Medtronic made up 0.32% of Dudley Capital Management's portfolio in Q2 2026, its #71 holding.
  • Dudley Capital Management first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Dudley Capital Management's Medtronic position peaked at $1.52M in Q2 2023.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Dudley Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.